Where does UCB Pharma S.A. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), UCB Pharma S.A. ranks #6,200 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does UCB Pharma S.A. hold?

UCB Pharma S.A. holds 55 US utility patents granted between 2015 and 2024, spanning 14 technology areas.

What is UCB Pharma S.A.'s Innovation Score?

UCB Pharma S.A. has an Innovation Score of 50.6 out of 100 (top 13% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does UCB Pharma S.A. focus on?

UCB Pharma S.A.'s top technology area is C07K (Peptides) with 41 patents, ranking #231 of 3,615 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

Is UCB Pharma S.A.'s patent grant rate increasing or decreasing?

UCB Pharma S.A.'s recent grant velocity is -90% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for UCB Pharma S.A.'s patents?

UCB Pharma S.A.'s patents average 16.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the UCB Pharma S.A. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

UCB Pharma S.A.

USPTO PatentsView assignee record - 55 granted patents across 14 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, UCB ranks #6,200 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 14 technology areas.

#6,200
of 49,997 US assignees by volume: Top 13%
by Innovation Score (50.6/100): 16.9
avg claims per patent: -90%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6200 · Foreign Corporation #6,200 · 55 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 55 grants
UPPER-Q #6,200/49,997
PHOTO-FINISH The North Face Apparel
CPC-FOCUS C07K · 14 areas
INNOV-PAR 50.6/100
CLAIMS-RICH 16.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -90% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: The North Face Apparel Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How UCB’s 50.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.9 pts (27%) Velocity 13.3 pts (26%) Breadth 13.2 pts (26%) Claim depth 10.2 pts (20%)

Qualcomm Incorporated · highest

85
Children's Hospital… · near

51
Gemalto · near

51
Namics · near

51
Shibaura Mechatronics · near

51
UCB Pharma · this assignee

51
3D Lighting… · lowest

7

What this shows UCB's Innovation Score is 50.6/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for UCB?

Each dot is one of UCB’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). UCB’s own 16.9 claims/patent is ABOVE the 16.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

UCB vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where UCB's grants concentrate

UCB Pharma S.A. is a focused PatentsView assignee: 14 CPC subclasses with 74.5% of grants classified under C07K (Peptides). Peak complete grant year is 2015 (26 grants) versus a trough of 1 in 2019. By volume, UCB sits between The North Face Apparel Corp. and W Schonbek LLC.

UCB's three-year grant acceleration

UCB Pharma S.A. shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

The North Face Ap…

55
The University of…

55
Theatro Labs

55
Tyco Safety Produ…

55
University Colleg…

55
University of New…

55
Vicor

55
W Schonbek

55
UCB Pharma ◀

55

What this shows UCB holds 55 patents at rank #6,199, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near UCB

By rank, the assignees closest to #6,199 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in UCB's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for UCB, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), UCB ranks #231 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (51 here).

Namics Corporation 51 Shibaura Mechatronics Corporation 51 Gemalto SA 51 Children's Hospital Los Angeles 51

Similar claim depth

Nearest assignees by average claims per patent (16.9 here).

Given Imaging Ltd. 16.9 avg HiDeep Inc. 16.9 avg University of Kansas 16.9 avg Integrated Device Technology, Inc. 16.9 avg

UCB's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 13% higher than 87% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

UCB Pharma S.A. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	26	47.3%
2016	11	20.0%
2017	9	16.4%
2018	3	5.5%
2019	1	1.8%
2020	1	1.8%
2022	1	1.8%
2023	2	3.6%
2024	1	1.8%

Which technologies does UCB Pharma S.A. patent most?

C07K - Peptides 41

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 24

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 20

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 17

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

C07D - Heterocyclic Compounds 7

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 6

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 3

C12Y - Enzymes 2

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

UCB Pharma S.A.'s patent record in context - here's where to go next.

UCB Pharma S.A.'s lead technology class is C07K (Peptides), 74.5% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #6,200 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare UCB Pharma S.A. against The North Face Apparel Corp., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.